Innovations in Industrial Paper Sacks to Be Centered Around Sustainability, Says FMI in its New Report

Environmentally sustainable industrial paper sacks are predicted to remain the most preferred, comprehensive, and state-of-the-art packaging solution for powered materials, as per a recent report by Future Market Insights (FMI), a multinational market intelligence firm. The global sales of industrial paper sacks is expected to generate approximately US$ 5.5 Billion, in 2019. Demand analysis indicates a moderate year-on-year growth rate of nearly 4.3 percent, during the same period. Superior functionality, sustainability and cost efficiency associated with industrial paper sacks, makes it a preferred packaging choice for numerous powdered goods such as flour, cement, and animal feed among others, thereby, increasing the sales revenue of industrial paper sacks.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-8176

Sustainability to Remain a Key Demand Driver

Industrial paper sacks demand is projected to remain promising considering improvement in four key areas, including reduction in electricity consumption, reduction in greenhouse emission, lesser fossil fuel consumption, and continuous improvements in carbon footprint. Packaging manufacturers are increasingly offering safe and effective solutions by incorporating highly sustainable materials in packaging.

In addition, manufacturers are optimizing the raw materials and enhancing sack construction to further improve the products’ sustainability credentials. Stringent government regulations banning plastic sacks will remain a critical factor pushing the demand for industrial paper sacks, in the global market.

Hybrid Industrial Paper Sacks Manufacturing to Open Opportunities

Since conventional industrial paper sacks tends to be rain and moisture sensitive, it weakens the packaging, thereby, affecting the shelf-life of the product. Manufacturers are increasingly using High-density polyethylene (HDPE) for a protective outer coating of the industrial paper sacks—resulting in hybrid paper-plastic sacks. Apart from offering an impressive outdoor performance and easy recyclability, the newly developed hybrid industrials sacks is projected to remain the most preferred packaging solution for construction materials such as cement and gypsum as well as other moisture-sensitive materials. The bag is even suitable for filling up content at temperatures of 90°C. Hybrid variants are also likely to streamline supply chain management.

“Weight-carrying limitations and weather-sensitivity of industrial paper sacks are some pain points being addressed by manufacturers. Billerudkorsnas, a key manufacturer of industrial paper sacks, has added waterproof industrial paper sacks to its product portfolio, thereby eliminating product waste and ensuring fast and higher filling speed”, Senior Analyst, Future Market Insights.

Industrial Paper Sacks Sales Concentrated in Emerging Markets

Developing markets of Asia Pacific (more than 1/4th of the total market share) are expected to exhibit substantial demand for industrial paper sacks, given the expanding urban landscape and building & construction industry. As per FMI analysis, China is predicted to remain in the fore, with a notable growth in production and consumption of industrial paper sacks, over the past decade. India, on the other hand, will remain a key revenue contributor, given the recent economic boom in the region.

In addition, high investments in the building & construction and agriculture industries are expected to create ample opportunities for manufacturers of industrial paper sacks, in the emerging markets.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-8176

Manufacturers Focus on Product Portfolio Expansion to Sustained Market Presence

In a highly fragmented landscape, tier-3 manufacturers of industrial paper sacks are projected to contribute approximately 70-80 percent revenue to the global market. However, tier-1 manufactures may prove dominance over the global industrial paper sacks market, in terms of their bargaining power, given their application-specific product offerings.

On the other hand, given the high competitiveness amongst manufacturers, threat of substitutes in the form of flexible intermediate bulk containers and heavy duty bags, with superior high capacity and strength, remains exceptionally high. The global industrial paper sacks market is most likely to offer opportunities to new entrants, considering expanding application across a host of end-use sectors.

“Manufacturers are focused on expanding their portfolios to cater to the growing demand from end users. In addition, there seems to be a key focus on design, to enable optimum consumer convenience, such as the temperature-controlled packaging. Industrial paper sacks manufacturers are also ramping up their production lines, designed to be compatible with sack filler machines”, Senior Analyst, FMI.

Key Insights from Segmental Analysis:

  • In terms of grade, unbleached industrial paper sacks is expected to maintain its dominance in terms of both, value and volume during the forecast period, with more than 70 percent market share.
  • Expanding at the most steady CAGR, less than 2-ply segment by thickness will remain the most preferred variant, versus 2 ply, 3 ply, and more than 3 ply categories. The less than 2 ply segment is expected to witness a peak y-o-y growth rate of 5.6 percent, during 2023-2025
  • Pinched bottom open mouth industrial paper sacks will witness maximum adoption given its applicability in packaging expensive or sensitive products.

Gamma Knife Market is expected to reach US$ 507.0 Million by 2031

[200 Pages Report] Future Market Insights (FMI) provides vital insights on the key regions in the global Gamma Knife market in its latest report, “Gamma Knife Market: Global Industry Analysis and Opportunity Assessment 2015-2025”. According to the report, Asia Pacific Excluding Japan (APEJ) will emerge as the most lucrative region for the global Gamma Knife market by the end of 2025.

FMI, in its research report, has covered the Gamma Knife market in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America Gamma Knife market, valued at US$ 46.3 Mn in 2014 will expand at a CAGR of 7.5% through 2025, reaching a valuation of over US$ 100 Mn by 2025.

Rise in geriatric population and preference for less time-consuming treatment are the key factors fuelling the Gamma Knife market in North America. Increase in the prevalence of cancer, coupled with shift towards painless and non-invasive surgeries are other key drivers of the market.

Rise in per capita healthcare expenditure is also fuelling the Gamma Knife market in North America. For example, 17.7% of America’s GDP was spent on healthcare in 2011. Increase in funding for R&D on non-invasive treatment is also providing an impetus to the Gamma Knife market in North America.

According to Cancer.org, in the US, nearly 1,658,370 new cancer cases are expected to be diagnosed in 2015. Owing to these new diagnoses, the demand for non-invasive treatment options is expected to witness a surge.

In terms of compound annual growth rate (CAGR) and market value, FMI expects Asia Pacific Excluding Japan (APEJ) to emerge as the most lucrative market by the end of forecast period.

Currently valued at US$ 43.9 Mn, the Asia Pacific Excluding Japan (APEJ) Gamma Knife market is projected to expand at over 10% CAGR through 2025, reaching a valuation of US$ 131.5 Mn. APEJ is expected to account for nearly 30% of the market value share of the global Gamma Knife market by 2025.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-589

The same factors that are driving the North America Gamma Knife market are fuelling the market in APEJ as well. However, the funding for research and development is expected to be comparatively lower than that in North America.

The leading companies operating in the Gamma Knife market are Elekta, Varian Medical Systems, and Huiheng Medical.

Gamma Knife tools account for nearly 40% of total revenues of Elekta. The company has a strong presence in North America and Europe. The company has strategic partnerships with prominent institutes, such as Swedish Cancer Institute and Ottawa Hospital.

FMI’s research on the Gamma Knife market revealed that approximately 950 employees at Elekta are involved in research and development activities. The company aims to exploit market opportunities and focus on radiotherapy market. The company’s capacity to drive the business further from the existing installed base becomes critical as it is subject to stringent market expectations.

North America is the most lucrative market for Varian Medical System, with the region accounting for nearly 46% of the total revenues. The company has a strong presence globally in terms of brand recognition and technology.

A key opportunity for Varian Medical System is to expand in invasive surgery equipment by leveraging established brands. However, lack in safety measures for patients and staff from high radiations.

The company is focusing on R&D activities for high-quality and software which require trained professional for usage and safety. These activities involve increasing interconnectivity of products for a seamless operation.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-589

Gamma Knife Market – Key Segment

By Disease Indication:

  • Brain Metastasis
  • Cancer
  • Arteriovenous Malformation (AVM)
  • Trigeminal Neuralgia
  • Others

By Anatomy:

  • Head
  • Neck
  • Other Body Parts

By Geography:

  • North America
  • Europe
  • APAC
  • Latin America
  • Middle East and Africa

Continuous Renal Replacement Therapy Market is likely to grow at a CAGR of 7.7% through 2027, reaching US$ 1.68 Billion.

[198 Pages Report] Acute kidney injury (AKI) is a common type of kidney disorder with high morbidity and mortality worldwide. Patients from low-resource regions are more prone to acute kidney injuries. The incidence of acute kidney injuries varies greatly in Asia due to significant variation in climate, geographical attributes, ethnic groups and socioeconomic status. The global continuous renal replacement therapy market was valued at US$ 1 Billion in terms of value in 2021, according to a latest research by Future Market Insights (FMI). The report on continuous renal replacement therapy further projects significant growth potential with average year-on-year growth rate of 7.7% through 2027.

Continuous renal replacement therapy is conducted for blood purification in patients suffering from acute kidney injury who unable to withstand rapid fluid and electrolyte exchange of conventional hemodialysis. Continuous renal replacement therapy involves the removal of blood from the arterial lumen catheter through the peristaltic movement and pushing it through a hemofilter before getting pumped into a patient via a venous lumen of catheter. Rising incidence of acute kidney injuries, multiple organ failure and other renal injuries had increased the demand for dialysis sessions.

Numerous advantages of continuous renal replacement therapy over the conventional dialysis procedure is a primary factor driving the adoption of continuous renal replacement therapy. Conventional dialysis systems are operated manually and all associated tasks are solely controlled by the user or caregiver. However, technological advancements in currently available continuous renal replacement systems allows the automatic management of disease parameters. Hence, most of the problems are being directly handled by automated digital machines, which is not possible in case of conventional systems, thus reducing the labour cost.

To expand their commercial footprint across the globe, several manufacturers of continuous renal replacement therapy are focusing on introducing new technologies and upgrading their existing products along with simultaneous focus on strategic alliances for the sale and promotion of their products. For instance, in 2015, Fresenius Medical Care AG & Co. KGaA launched multi Filtrate PRO, a therapy system for continuous renal replacement therapy for the treatment of acute kidney failure in critically ill patients at intensive care units. Innovations in extracorporeal technologies will play a critical role in the long-term sustainability of continuous renal replacement therapy devices. The advent of continuous renal replacement therapy devices will eventually attract a new patient base. For instance, in September 2017, Baxter International Inc. launched 3-In-1 oXiris Set for sepsis management protocols & continuous renal replacement therapy, which was previously indicated only for continuous renal replacement therapy. The commercialisation of such multimodal devices is expected to enhance the ROI for hospitals. The introduction of novel autonomous CRRT devices will marginally reduce physician intervention and the cost of treatments in intensive care units. The intuitive platform with touch screen and step-by-step automated instructions promotes ease of use during procedures.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1211

Companies are investing in future growth by expanding their healthcare services businesses through acquisitions as well as the purchase of expertise and relevant technologies in the area of research and development. In 2016, Fresenius Medical Care spent US$1.3 Bn on capital expenditures, acquisitions and the purchase of intangible assets minus income from divestments. The majority of capital expenditures were used for equipping existing & new clinics, preserving & expanding production capacity, primarily in North America, Germany, Asia Pacific and France, as well as for dialysis machines made available to customers and for care coordination.

FMI segmented the global continuous renal replacement therapy market into product type, end user & regions. In terms of revenue, the consumables segment is expected to hold a substantial market share over the forecast period. The segment is expected to exhibit a significant CAGR of 8.5% over the forecast period.

FMI’s report covers some of the key companies operating in the continuous renal replacement therapy market, which include Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG; Medica SpA, Nikkiso Co., Ltd.; Nipro corp.; Toray Medical Co., Ltd.; NxStage Medical, Inc.; Asahi Kasei Corp. and Medtronic plc.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1211

SegmentationThe report offers a comprehensive taxonomy of the continuous renal replacement therapy market based on product type, end user and region. Continuous renal replacement therapy is sold in two types: systems and consumables. The consumables segment covers various types of hemofilter sets, solutions and other accessories.

Increased healthcare spending across emerging economies is expected to encourage the establishment of new multi-specialties in dialysis centres and hospitals, which is, in turn, expected to promote the demand for CRRT. The continuous renal replacement therapy market has been analysed across various regions, which include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan and MEA.

Ocular Drug Delivery System Market to surpass US$ 14,471.2 Million in valuation by the end of 2021

[250 Pages Report] According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031.

Ocular drug delivery systems are designed for dispensing drug, biologic, biopharmaceutical, and botanical therapeutics for treating macular degeneration, glaucoma, presbyopia, allergy, anti-viral, dry eye, anti-infective and anti-inflammatory indications.

To overcome the ocular drug delivery barriers and improve ocular bioavailability, various conventional and novel drug delivery systems have been developed such as  ointments, emulsion, suspensions, aqueous gels, Nano micelles, liposomes, , and in situ thermosensitive gels for the earlier mention ocular diseases.

Glaucoma is the second-leading cause of blindness worldwide, accounting for up to 8% of total blindness. In India, glaucoma is the leading cause of irreversible blindness with at least 12 million people affected and nearly 1.2 million people blind from the disease. More than 90 percent of glaucoma cases remain undiagnosed in the community.

Thus the high incidence of ophthalmic diseases, resulting in the rise significant patient population, is driving the global ocular drug delivery systems market.

Ocular drug has to pass the water-fat-water membranous structure of cornea and this changing environment presents a significant barrier. That is why, for almost four decades, researchers have been involved in developing intraocular sustained-release drug delivery platforms.

Owing to the rigorous research studies, approvals for new ocular drug delivery techniques are currently recorded globally. This has helped the market to gain momentum over the last few years.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6027

Key Takeaways from Ocular Drug Delivery System Market Study

  • Increasing focus on pharmaceutical innovation and research on drug delivery technologies is driving a transition towards particulate drug delivery systems, which will account for over 68% of the market in 2021.
  • Ophthalmic solution for ocular drug delivery system is expected to account for 60% the global market share by 2031.
  • Among distribution channels, hospital pharmacies accounted for 40% of the market share in 2031. Soaring influx of patients for treatment and availability of intensive care support have propelled the demand in the sehment.
  • North America holds the maximum share, owing to the presence of Tier1 players, high per-capita healthcare expenditure, and favorable reimbursement policies in the region.
  • The U.S. holds a more than 44% share in the global ocular drug delivery systems market.
  • The U.K. and Germany are leading markets in Europe, accounting for more than 41% of the Europe market in 2021.
  • South Korea is the fastest growing market in East Asia, exhibiting 10.3% CAGR through 2031.

“Increasing prevalence of eye infections, innovation in drug delivery technologies, and rising clinical trials are creating lucrative growth opportunities for ocular drug delivery system sales,” says the Future Market Insight analyst.

Increase in Funding for Research Activities Offers Growth OpportunitiesLeading manufacturers in the ocular drug delivery system market are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research pharmaceutical products.

For instance, In April, 2017, Santen Pharmaceuticals announced a strategic investment in Regenerative Patch Technologies LLC, a U.S. based company engaged in development of ophthalmic therapies.

Pharmaceutical giants are expected to benefit from the globalization of labor forces, that is, employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.

As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6027

Who is Winning?The global market is set to expand due to the rising prevalence of eye infections. Leading players within this space are expected to focus on research and development to offer an early and precise diagnosis of ailment, besides offering effective patient care.

Some of the leading players in the ocular drug delivery system market include but are not limited to Allergan Plc., Graybug Vision Inc., Ocular Therapeutix, Inc., Alimera Sciences, pSivida, Santen Pharmaceutical Co., Ltd, Taiwan Liposome Company Ltd., Envisia Therapeutics, Eyegate Pharma, Valeant Pharmaceuticals International, Inc, Vision Ophthalmology Group GmbH, Clearside Biomedical, URSAPHARM Arzneimittel GmbH.

Want More Insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global ocular drug delivery systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the ocular drug delivery systems treatment on basis of the key indication in detail, cover every aspect of the market such as technology, dosage form, distribution channel across seven major regions.

Ocular Drug Delivery Systems Market by CategoryTechnology

  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System

Dosage Form

  • Ophthalmic Solution
  • Ophthalmic Suspension
  • Ophthalmic Emulsion
  • Ophthalmic Gels
  • Ophthalmic Ointments

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Store
  • Mail Order Pharmacies

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6027

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Teleradiology Market to reach a valuation of US$ 14.8 Billion by 2026

As per a study by ESOMAR-certified consulting firm Future Market Insights (FMI), the global teleradiology market is expected to surpass a valuation of US$ 5.15 Bn through 2021. Favored by the increasing number of medical imaging procedures such as computed tomography (CT) scans and X-ray scans, the sales of teleradiology are likely to surge at a vigorous 12.18% CAGR during the assessment period.

Rising prevalence of diseases such as cancer, arthritis, cellulitis, and osteomyelitis are facilitating the market growth. According to the National Institute of Cancer, around 1898,160 new incidences of cancer are estimated to be diagnosed in 2021, causing approximately 608,570 deaths in the U.S.

As teleradiology enables the transfer of radiological images to qualified radiologists for providing effective treatments, it plays a life-saving function for patients. Thus, with the increasing number of cancer cases and lack of availability of skilled radiologists in sub-urban and rural areas, the demand for teleradiology systems is likely to increase over the coming year.

The coronavirus outbreak has favored the teleradiology market by increasing demand for medical imaging procedures across the globe. As the use of teleradiology systems avoids in-person contacts for the exchange of hard imaging result copies, these systems are increasingly being adopted by hospitals, medical institutes, and clinics for sharing study observations and details information gathered, thereby, driving teleradiology sales.

“Key players in the market are integrating novel technologies such as artificial intelligence (AI), cloud-based solutions, and picture archiving and communication system (PACS) for developing innovative teleradiology solutions as they aim at capitalizing on the increasing demand of accurate diagnosis,” says the FMI’s analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1747

Key Takeaways from FMI’s Teleradiology Market StudySales of teleradiology systems are expected to rise at 9.10% between 2020 and 2021.

  • The U.S. is estimated to dominate the North America teleradiology market owing to the presence of leading market players in the country.
  • China is likely to emerge as the prominent market in Asia Pacific due to the high prevalence of chronic diseases such as cancer and arthritis.
  • Based on modality, CT scans are anticipated to lead the segment, on the back of rising digitalization and technological advancements in the segment.
  • Owing to the surging demand for diagnostic imaging procedures due to the lack of qualified radiologists, ambulatory imaging centres (AICs) are expected to account for substantial revenue share.

Competitive LandscapeTeleradiology Solutions, Argus Radiology, SRL Diagnostics, USARAD Holdings, Inc., Vital Radiology Services, and Telemedicine Clinic are the leading players operating in the teleradiology market as profiled by FMI.

The teleradiology market is highly fragmented owing to the presence of large number of market players. Leading player emphasizing on launching the new products and expanding their product portfolio to gain competitive edge over other player. Besides, this some of the players are adopting strategies such as strategic collaboration, merger, acquisition, and partnership with other industry players to strength their market footprint. For instance,

  • In February 2021, Medica Group, teleradiology provider headquartered in the U.K. announced entering in a joint venture partnership with MedX, a Canada-based pharmaceutical logistics and supply chain company. The strategy will help the Medica Group providing teleradiology reporting service in New Zealand, Australia, and Ireland
  • Recently Vital Radiology Services, an international teleradiology service provider company headquartered in India, announced entering into a partnership with one the largest medical imaging providers in the world, I-MED Radiology Network. This partnership will assist both the companies to bring innovation in the domain to a new level.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1747

More Insights into the Teleradiology Market ReportIn its latest report, FMI offers an unbiased analysis of the global teleradiology market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of modality (X-Ray scans, CT scans, MRI scans, ultrasound scans, nuclear scan, cardiac echo, mammography, and electromammography), and end user (hospitals, clinics, ambulatory surgical centres, and radiology centres), across U.S. and Other than U.S. (Latin America, Europe, Asia Pacific excluding Japan, Japan, and Rest of the World)

Teleradiology Market by CategoryBy Modality:

  • X-Ray Scans
  • CT Scans
  • MRI Scans
  • Ultrasound Scans
  • Nuclear Scan
  • Cardiac Echo
  • Mammography
  • Electromammography

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Radiology Centres

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1747

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East & Africa (MEA)

Increasing Digitalization to Impact the Demand for Copier Paper Across the World

Future Market Insights (FMI) delivers key insights on the global copier paper market in its published report, titled “Copier Paper Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2027”. Globally, the revenue generated from the sales of copier paper is estimated to be around US$ 14,278.9 Mn in 2018, and is projected to expand at a CAGR of 1.2%, during the forecast period 2018-2027. This can be attributed to numerous factors, about which Future Market Insights offers thorough insights and forecast in the copier paper market report.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-6556

Copier Paper is a light-weight paper used for copying, writing, and printing in either commercial or consumer applications. Copier paper falls under the category of uncoated freesheet grade and is used interchangeably with printing paper for everyday printing needs. Using copier paper instead of printing paper does not make much of a difference for written content but for image printing, a thicker printing paper sheet needs to be used. Copier paper can be made out of virgin as well as recycled pulp. Leading manufacturers of copier paper such as Nine Dragons Paper, Nippon Paper, and Domtar Corporation, use recycled pulp for the production of copier paper.

FMI Key Findings

  • Among the various thicknesses, the 50-80 GSM segment is witnessing higher growth and is projected to have a positive outlook during the forecast period. It is the most commonly used thickness for everyday commercial as well as consumer printing needs.
  • Virgin copier paper holds a significant share in the copier paper market, but with the rising environmental concerns, manufacturers are using recycled pulp for copier paper production. For instance,
    • Nine Dragons, one of the leading paper manufacturers, primarily uses recycled paper as the main raw material source. The company recycles over 10 million Tonnes of fiber annually.
  • The advent of digitalization has impacted the overall graphic paper market adversely. The growth in demand for copier paper has slowed down in recent years. With the increased penetration of electronic devices and easier access to the internet, reading content online has become a trend, and electronic devices are being substituted for hard-copies. This is expected to hamper the demand for copier paper during the forecast period. However, there is a steady demand for copier paper among educational institutes as well as offices. The degree of substitution is relatively low in scientific and technological content.
  • The A/4 segment in the global copier paper market is the most preferred paper size for copier paper, followed by the A/3 segment. Most of the commercial copying is done using A/4 copier papers.

Developing Economies to Fuel the Demand for Copier Paper During the Forecast Period

Despite facing a decline in the developed markets, copier paper has seen an increase in demand in the developing economies. This can be attributed to the growing number of students in rural as well as urban areas. Overall, the Asian copier paper market is anticipated to show strong growth throughout the decade. Apart from Japan, the Asian market is expected to grow at a healthy CAGR. Latin America and Africa also represent attractive opportunities for growth. Paper manufacturers are performing strategic mergers and acquisitions to expand their presence in these markets and leverage the most out of the landscape. Consolidation is seen as a key strategy at the aggregate level, as paper manufacturers understand the declining nature of the market.

Toc of the Report : https://www.futuremarketinsights.com/toc/rep-gb-6556

The key players in the global copier paper market are International Paper Company, North Pacific Paper Company, South Coast Paper LLC, UPM-Kymmene Oyj, Domtar Corporation, Nippon Paper Industries Co., Ltd., Mondi Group plc, Stora Enso Oyj, Smurfit Kappa Group Plc., Oji Holdings Corporation, Lisgop Sikar L’td., Georgia-Pacific LLC, Nine Dragons Paper (Holdings) Limited, Sappi Limited, Metsa Board Corporation, Daio Paper Corporation, Pratt Industries, Inc., Svenska Cellulosa Aktiebolaget (SCA), Packaging Corporation of America (Boise Paper), and Rolland Enterprises Inc. Many local and unorganized players are anticipated to contribute to the global copier paper market during the forecast period.

Aluminium Aerosol Cans Consumption to Cross US$ 3.5 Billion in 2019

In a new intelligence study, Future Market Insights projects the global sales of aluminium aerosol cans to exceed the valuation of US$ 3.5 Bn in 2019. The yearly revenue growth of aluminium aerosol cans market in 2019 is estimated at a promising rate of 5.3%, reports the FMI analyst.

As indicated by the British Aerosol Manufacturers’ Association (BAMA), the US and China remain the top producers of aerosols worldwide. Europe alone has witnessed around 5 billion aerosol products in 2017, where the UK is the most significantly contributing market.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-2165

“Europe remains the top consumer of aerosol containers owing to briskly expanding application base across multiple end use verticals. Russia’s thriving agricultural market is especially raising substantial demand for aluminium aerosol cans for pesticides and insecticides, in recent past. Towards the end of 2019, Europe’s aluminium aerosol cans landscape is projected to account for over 1/3rd of the global market revenue,” says the analyst.

Aluminium aerosol cans, lightweight and economical, constitute the most popularly sought after aerosol container across a range of verticals. There are nearly 200 distinct end uses of aerosols, prominently including personal care, furnishing, painting, cleaning, household, medical and pharmaceutical products, inhalers, and automotive products.

The analyst quickly explains market taxonomy, “Consistently improving lifestyle, robust demand for convenience products, and growing affordability continue to foster the prospects of aluminium aerosol cans at a global level. While Necked-In aluminium aerosol cans are likely to be the most popular type globally, more than 500ml capacity containers remain the most preferred among consumers. Moreover, household cleaning, cosmetics, and personal care are projected for higher yearly growth rates in 2019 and beyond”.

Competition Tracking & Key Players Trend Analysis

Expansion

Expansion of aluminium aerosol cans production as well as aerosol filling has been among the key strategies of leading market companies, of late. Aryum Aerosol Cans Ltd. recently established a new aerosol filling facility in Turkey and looks forward to lead the chunk of aluminium aerosol cans manufacturers based across Middle East and Eastern Europe.

Sustainability

Following the no-coating aluminium aerosol cans introduced by Tubex that heavily contribute to reduced ecological footprint, a number of companies are focusing on catering to ecofriendly production, packaging, and disposal. Ball Corporation is focusing on the supply of sustainable and innovative F&B and household product packaging solutions, besides expanding the capacity expansion for extruded aluminium aerosol cans production. Teaming up with Unilever, Ball is likely to add to the sustainability quotient of aluminium aerosol cans by manufacturing recyclable and lightweight containers, with ReAl technology.

Toc of the Report : https://www.futuremarketinsights.com/toc/rep-gb-2165

Advanced Technology

Ball Corporation has become the first brand to debut in the incorporation of photorealistic printing technology in aerosol packaging. Ball’s Aerosol Packaging Division recently announced the company’s entry into this ‘unparalleled’ next-generation HD photorealistic printing technology on aluminium aerosol cans. The company explains that this technology allows printing over 3600 degrees, without digital printing. Though currently available only across North American, European, and Indian markets, the company is strategizing the release of these aluminium aerosol cans across the globe.

Aluminium Supply Agreements

Market players are also signing long-term supply agreements with leading aluminium producing brands. The proprietary aluminium alloy of Constellium N.V., the aluminium production giant, will be now supplied to Czech-based aluminium aerosol cans producer. The latter will dedicate this supply for Unilever’s Dove antiperspirants’ line.

Some of the prominent competitors actively operating in the global aluminium aerosol cans landscape, include TUBEX GmbH, Casablanca Industries Pvt. Ltd., Exal Corporation, Crown Holdings, Inc., Euro Asia Packaging (EAP), Ardagh Group S.A., Bharat Containers, and a few others. The report presents an extensive attempt of profiling a broad list of prominent players in the aluminium aerosol cans market – covering their key developmental strategies.

Tissue Engineered Skin Substitute Market is expected to reach US$ 4.13 Billion by 2029

[248 Pages Report] Rapid expansion of wound management space has argued well for the growth in demand for tissue engineered skin substitutes. The global tissue engineered skin substitute market is projected for a robust 9.6% CAGR during 2022 – 2029, predominantly driven by high applicability in diabetic foot ulcers and other chronic wounds.

With advent of tissue engineering and improved ability to combine advanced manufacturing technologies with biomaterials and cell culture systems, more biomimetic tissue constructs have been emerged. Technological advancements are leading to production of advanced tissue engineered skin substitutes. 3D bioprinting and biotextile are emerging as popular biofabrication strategies for creating bioengineered skin substitutes. A team of researchers in the U.S. recently discovered a technology for complete 3D printing of the living skin along with blood vessels. Emergence of such revolutionary fabrication technologies will create a massive opportunity in the global market.

Despite breakthrough innovations assisting the growth of market, certain limitations are still there. The inability of tissue engineered skin substitutes to produce skin appendages such as hair follicles, sebaceous glands, and nails continues to remain among the most concerning challenges facing R&D teams

Key Takeaways – Tissue Engineered Skin Substitute Market Study

  • With increasing researches in tissue engineering, the demand for   biologic skin substitute is expected to increase in the forecast period. For instance, a team of engineers at the California Institute of Technology (Caltech) and ETH Zurich have developed an artificial skin made from pectin, a naturally occurring long-chain molecule present in plant cell walls allowing the construction of natural and new dermis.
  • Increasing prevalence of diabetes and chronic wounds is boosting the demand for tissue engineered skin substitutes.
  • The demand for tissue engineered skin substitutes in emerging economies such as China and India is expected to increase owing to increasing incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-781

Leading Manufacturers Setting the Pace for Product InnovationsThe tissue engineered skin substitute market is a consolidated market. The tier 1 companies in the tissue engineered skin substitute market such as Allergan Plc., Mimedex Group Inc., Integra LifeSciences Corp. and Integra LifeSciences Corp. are expected to hold more than half of the total revenue generated by tissue engineered skin substitutes. The key players in the market are reshaping their current product portfolio by focusing on the introduction of new and advanced technologies and innovating new products.

Seeking More Insights?Tissue engineered skin substitute market, a new study from Future Market Insights, opines on the evolution of tissue engineered substitute market from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of; product (acellular skin substitute, biologic skin substitute, cellular skin substitute and synthetic substitute), material (synthetic and natural), application (chronic wound, acute wound and other applications such as breast reconstruction etc.) and end user (hospital, specialty clinics, ambulatory surgical centres and research laboratories) across seven prominent regions.

Tissue Engineered Skin Substitute Market by CategoryBy Product:

  • Acellular Skin Substitutes
    • Acellular skin substitutes based on Amniotic Membrane
    • Other Acellular skin substitutes
  • Biologic Skin Substitute
    • Allograft
    • Xenograft
  • Cellular Skin Substitutes
    • Cellular skin substitute based on amniotic membrane
    • Other cellular skin substitutes
  • Synthetic Skin Substitutes

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-781

By Material:

  • Synthetic
  • Natural

By Application:

  • Chronic Wounds
    • Venous leg Ulcers
    • Diabetic Foot Ulcer
    • Pressure Ulcers
  • Acute Wounds
    • Traumatic Wounds
    • Burn Cases
  • Other Applications

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/781

Over US$ 50 Bn Revenue Forecast for HDPE Bottles in H2 2019; FMI Spots Most Lucrative Opportunities in Beauty & Personal Care Circle

High density polyethylene (HDPE), one of the most durable and versatile forms of thermoplastics, is gradually gaining the title of a preferred packaging material at a sluggish pace. While the top sought attributes of HDPE include high strength-to-density ratio, weatherproof nature, chemical resistance, lightweight characteristics, and economical price point, it more importantly meets the FDA and USDA standards that are mandatory especially in case of the use of HDPE bottles in food and beverages sector.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-7598

Projected to cross the US$ 50 billion mark in 2019, the global revenue of HDPE bottles landscape is likely to expand gradually year on year. As explained in a new research study presented by Future Market Insights, the global HDPE bottles market will demonstrate passive growth over the next few years; however, increasing inclination towards adoption of HDPE as a raw material over conventional thermoplastics is likely to be witnessed.

High Recyclability Accounts for Growing Popularity of HDPE Bottles

Low quantity chemicals as well as drugs used for household or OTC applications are generally packaged in HDPE bottles. A widely preferred container for chemical products, HDPE bottles are highly recyclable. As the recycling process is relatively less complicated and more efficient, packaging manufacturers are gradually inclining towards HDPE as a raw material for packaging a range of products. Being one of the most considerate and least permeable packaging formats, HDPE bottles are likely to find widening applicability in packaging.

Asia Pacific Secures the HDPE Production Hub Title for Manufacturers of HDPE Bottles

Asia Pacific, especially China, has been contributing significantly to the global HDPE production capacity over the years and according to FMI’s study, APAC remains a significant HDPE producer in the near future. North America and Europe also stand important in sustaining the HDPE production scenario, whereas the report indicates promising performance of the Middle Eastern & African region.

HDPE Bottles Find Growing Applications in Personal & Home Care Products and Cosmetics

HDPE bottles are prominently used in the F&B, automotive, personal care & hygiene, and household care segments. Besides F&B, pharmaceuticals also register a decent rate of adoption of HDPE bottles owing to being reliable in terms of safety of packaged food and beverage products. The study points to dramatically growing per capita expenditure on personal care and beauty products worldwide, especially in developing economies. Escalating sales of bath and shower products, dermatological products, and essential toiletries are translating into increasing volume sales of HDPE bottles.

Globally, over 100,000 HDPE bottles are expected to be sold by this year’s end. Growing consumer spending power is playing a vital role in popularizing the usage of HDPE bottles among packaging companies serving the personal care and cosmetics industry. Moreover, the widening expanse of Ecommerce is encouraging demand for HDPE bottles for a plethora of products across industries.

Toc of the Report : https://www.futuremarketinsights.com/toc/rep-gb-7598

Is Recycled HDPE the Sustainable Solution to Cost Optimization?

With an emerging alternative of recycled HDPE bottles, manufacturers are striving to reduce dependency on the prices of raw materials. While high raw material cost has been a longstanding factor suppressing wide adoption of HDPE bottles for packaging, manufacturers are gradually opting for the usage of recycled HDPE material for manufacturing HDPE bottles. Unilever recently launched recycled HDPE bottles of a few recognized Australian brands selling personal and home care products, in ANZ. The brands involved are Dove, Sunsilk, Surf, OMO, and TRESemmé.

Leading packaging manufacturers are prominently focusing on developing sustainable HDPE packaging solutions to meet stringent regulatory standards set by governments of various countries. However, as the pricing volatility prevails in the HDPE bottles landscape, it is most likely to pose a negative influence on the future of HDPE in packaging. The HDPE bottles market analysis by FMI offers deeper insights on how superior material alternatives such as PET and LDPE are restricting rapid penetration of HDPE bottles. 

F&B Holds a Lion’s Share in Folding Gluing Machines Application, Year-on-Year Revenue Increase Projected at Just Under 4% in H2 2022: New FMI Study

Riding on the steady demand over the recent past due to the successful intervention of industrial automation, automatic folding gluing machines hold clear dominance over semi-automatic counterparts in the folding gluing machines landscape. Steady adoption of semi-automatic folding gluing machines however prevails among SMEs targeting higher production line efficiency.

A new research intelligence report published by Future Market Insights offers a deep-dive view of the folding gluing machines landscape, delivering exclusive insights on the most impactful push and pull factors associated with revenue growth.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-7595

Key Insights Drawn from the Global Folding Gluing Machines Market Report

  • The global revenue through folding gluing machines will surpass a value of US$ 5 Bn by this year’s end, witnessing a moderate Y-o-Y growth of around 4% over 2021.
  • Straight line and crash lock fold types of folding gluing machines collectively hold a massive value share of over 60%.
  • Food and beverages register maximum consumption of folding gluing machines.
  • Highest growth potential exists in Asia Pacific, in terms of adoption of folding gluing machines.
  • Sales of automatic folding gluing machines account for more than 80% of the total market revenue.
  • Introduction of more compatible, communicative, and ergonomically designed folding gluing machines is trending the market, targeting enhanced productivity at reduced costs.
  • Customized corrugated packaging trend in the E-commerce/E-tail world is playing a vital role in fueling sales of innovative folding gluing machines.

Convenience Foods Uphold F&B to Remain Largest End Use Sector Utilizing Folding Gluing Machines

In 2017, the global consumer expenditure on food and beverage products was registered roughly around US$ 6.5 trillion, i.e. nearly 8.5% of the GDP. F&B sector accounts for a remunerative 55% share in the folding gluing machines landscape, according to the Future Market Insights’ study.

Food sector, the top consumer of folding gluing machines, is witnessing a prominent push to revenue generation through dry foods and snacks segment. “The popular wave of processed, packaged, and convenience foods is substantially driving the demand for folding gluing machines worldwide, especially in developing Asian economies where the growth is likely to be concentrated in the near future,” explains a senior research analyst at FMI.

Moreover, frozen and chilled food products are contributing a sizable revenue share to folding gluing machines market. The analyst uncovers, “Non-alcoholic beverages continue to bring in lucrative business opportunities for folding gluing machines manufacturers, enabling beverages segment to secure the second end user sport in folding gluing machines market”.

Toc of the Report : https://www.futuremarketinsights.com/toc/rep-gb-7595

Rewarding Opportunities Reside in APAC, 1/3rd of Region’s Revenue Belongs to India & ASEAN Countries

The regulatory bodies based in Asian economies are pushing investments in manufacturing sector which have been translating into steadily growing demand for folding gluing machines in recent years. As reported by FMI’s study on global folding gluing machines landscape, India and ASEAN countries collectively account for around 1/3rd share in Asia Pacific’s market value.

Strong presence of a large number of F&B manufacturers within the region are predominantly shaping the adoption pattern of folding gluing machines. Moreover, India’s per capita packaging consumption was on an average 5.5 kg in 2017, pointing to an ample opportunities for folding gluing machines adoption.

Western European market for folding gluing machines is driven by favorable orientation of manufacturers towards industrial automation. North American market is however expanding at a relatively lower pace owing to consistently falling beverage consumption levels.

Leading manufacturers of folding gluing machines are investing considerable R&D efforts in innovating existing product lines for a decent competitive edge. While reduction of the overall change-over time takes up the spotlight, advanced technology integration also remains one of the key strategies of companies. MNCs are prudently focusing on tapping in to lucrative opportunities in developing Asian economies. Merging with regional leaders or acquiring unorganized regional players are currently the preferred strategic moves of manufacturers of folding gluing machines.